New-generation endocytoscopy for optical characterization of elevated-type early gastric cancer

Endoscopy ◽  
2021 ◽  
Author(s):  
Wen-Lun Wang ◽  
Hsiu-Po Wang ◽  
Ming-Lun Han ◽  
Ching-Tai Lee
2003 ◽  
Vol 29 (5) ◽  
pp. S179
Author(s):  
M. Kubo ◽  
M. Masuzawa ◽  
A. Kaneko ◽  
A. Nakama ◽  
K. Fujimoto ◽  
...  

2021 ◽  
Vol 22 (13) ◽  
pp. 6652
Author(s):  
Serena Battista ◽  
Maria Raffaella Ambrosio ◽  
Francesco Limarzi ◽  
Graziana Gallo ◽  
Luca Saragoni

Prognosis of gastric cancer is dramatically improved by early diagnosis. Correa’s cascade correlates the expression of some molecular markers with the progression of preneoplastic lesions toward carcinoma. This article reviews the diagnostic and prognostic values of molecular markers in complete (MUC2) and incomplete (MUC2, MUC5AC, and MUC6) intestinal metaplasia, gastric dysplasia/intra-epithelial neoplasia, and early gastric cancer. In particular, considering preinvasive neoplasia and early gastric cancer, some studies have demonstrated a correlation between molecular alterations and prognosis, for example, mucins phenotype in gastric dysplasia, and GATA6, TP53 mutation/LOH and MUC6 in early gastric cancer. Moreover, this review considers novelties from the literature regarding the (immuno)histochemical characterization of diffuse-type/signet ring cell gastric cancer, with particular attention to clinical outcomes of patients. The aim of this review is the evaluation of the state of the art regarding suitable biomarkers used in the pre-surgical phase, which can distinguish patients with different prognoses and help decide the best therapeutic strategy.


2014 ◽  
Vol 79 (5) ◽  
pp. 712 ◽  
Author(s):  
Nikolas Eleftheriadis ◽  
Haruhiro Inoue ◽  
Haruo Ikeda ◽  
Manabu Onimaru ◽  
Akira Yoshida ◽  
...  

2013 ◽  
Vol 25 ◽  
pp. 44-54 ◽  
Author(s):  
Kenshi Yao ◽  
Takashi Nagahama ◽  
Toshiyuki Matsui ◽  
Akinori Iwashita

2019 ◽  
Vol 07 (12) ◽  
pp. E1683-E1690
Author(s):  
Masaki Nishitani ◽  
Naohiro Yoshida ◽  
Shigetsugu Tsuji ◽  
Teppei Masunaga ◽  
Hirokazu Hirai ◽  
...  

Abstract Background and study aims No recommendations are available for optimal number of endoscopic biopsies for early gastric cancer (GC), and whether detection of early GC is improved by increasing the number of biopsy is unclear. We therefore evaluated the relationship between number of biopsies and diagnostic accuracy. Materials and methods We retrospectively evaluated 858 early GCs (623 from endoscopic submucosal dissection and 235 surgical specimens), which we classified as obtained after one, two, or three or more biopsies. We assessed diagnostic accuracy by number of biopsies, and in subgroups by tumor diameter, gross type, and surface color. Results Almost half the lesions were obtained after one biopsy each, 30 % after two biopsies, and 20 % after three or more biopsies. Although diagnostic accuracy increased with biopsy number, it was significantly greater for the two-biopsy group than the one-biopsy group, (92.5 % vs. 83.9 %, P = 0.0009), but did not significantly differ between the two- and three or more-biopsy groups. This finding was seen when tumors were evaluated by size, but not by elevated type and surface color, for which more biopsies did not improve diagnostic accuracy. Multivariate analysis demonstrated that two or more biopsies was the independent significant factors for diagnostic accuracy. Conclusions Two biopsies are the optimal number required to diagnose early GC.


Sign in / Sign up

Export Citation Format

Share Document